GenVec, Inc. (GNVC)
$1.00
-0.02 (-1.97%)
| CAPS Rating |
|
|---|---|
| Open | $0.96 |
| Previous Close | $1.02 |
| Daily Range | $0.95 - $1.04 |
| 52-Week Range | $0.01 - $1.17 |
| Market Cap | $106.33M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 621,897 |
| Average Daily Volume | 1,877,000 |
GNVC
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
GNVC Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
GNVC News and Commentary
- GenVec signs $22 mln vaccine contract, shares up – Reuters
- HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 4 – Reuters
- UPDATE 1-GenVec cancer drug gets orphan status, shares soar – Reuters
- 5 Stocks Approaching Greatness – The Motley Fool
- Monday's Biggest Stock Stars – The Motley Fool
- 7 Highly Rated Stocks on Sale – The Motley Fool
- 5 Top Microcap Stocks – The Motley Fool
Related News and Articles
- This Big Winner Has Hit Its Prime – The Motley Fool
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
RSS Headlines
Fool UK
